Over-75 and vulnerable to be offered another Covid booster in spring

A further booster jab for vulnerable in autumn 2022 is likely to be needed, says the JCVI

<p>Eldery people in the UK are to receive a second booster dose of the Covid vaccine </p>

Eldery people in the UK are to receive a second booster dose of the Covid vaccine

People at higher risk from Covid will be offered a fourth dose of a vaccine from spring, the government has confirmed.

Over-75s and vulnerable younger people will be offered a second booster jab to help protect against severe symptoms, as revealed on Sunday by The Independent.

The government’s Joint Committee on Vaccination and Immunisation (JCVI) has advised an additional booster, for over-75s and people aged over 12 who are immunocompromised, should be offered the jab six months after their last vaccine.

The vaccines used in the spring programme will be the 50mcg Moderna vaccine or 30mcg Pfizer/BioNTech vaccine for adults aged 18 and over.

The JCVI also said a further booster in autumn this year is likely to be advised for those who are at high risk.

The autumn jab campaign is expected to cover a wider group of people than in the spring and could include any new Covid vaccines that are available. It has not yet been decided whether all those currently eligible for an annual flu vaccination will be included.

The news comes as prime minister Boris Johnson is expected to confirm the ending of coronavirus restrictions, in its “living with Covid” strategy on Monday evening.

Plans to better protect Britain’s clinically vulnerable groups come as nearly 20 charities warned that people with immunocompromised systems risk becoming the “pandemic’s forgotten victims” under the government’s strategy for “living with Covid”.

In a statement, health and social care secretary Sajid Javid said: “Today I have accepted the advice from the independent Joint Committee on Vaccination and Immunisation (JCVI) to offer, from spring, an additional Covid-19 booster jab to people aged 75 years and over, residents in care homes for older adults, and people aged 12 years and over who are immunosuppressed. All four parts of the UK intend to follow the JCVI’s advice.”

He said the NHS would set out further details on these vaccinations “in due course” and that the JCVI would “keep under review” whether to give boosters to further at risk groups.

The JCVI said that“despite uncertainties around how the pandemic will develop through the summer” it “believes winter is likely to remain the season when the threat from Covid-19 is greatest, both for individuals and the NHS and care homes”.

In a statement, it added: “As such, the JCVI has provided additional interim advice to ministers for the purposes of forward planning that a further booster in the autumn of 2022 is likely to be advised for people who are at higher risk of severe Covid-19.”

Professor Wei Shen Lim, chair of Covid vaccination on the JCVI, said: “Last year’s booster vaccination programme has so far provided excellent protection against severe Covid.

“To maintain high levels of protection for the most vulnerable individuals in the population, an extra spring dose of vaccine is advised ahead of an expected autumn booster programme later this year.

“The JCVI will continue its rolling review of the vaccination programme and the epidemiological situation, particularly in relation to the timing and value of doses for less vulnerable older adults and those in clinical risk groups ahead of autumn 2022.”

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in